Why Thermo Fisher (TMO) is Skyrocketing in 2025? - MSN

On the stock market side, Thermo Fisher (NYSE:TMO) had hovered in the low-to-mid-$500s in early January 2025. In my view, that reticence is pretty standard for a large-cap science services ...

$500
OFF

Why Thermo Fisher (TMO) Is Skyrocketing In 2025? - MSN

2 weeks from now

On the stock market side, Thermo Fisher (NYSE:TMO) had hovered in the low-to-mid-$500s in early January 2025. In my view, that reticence is pretty standard for a large-cap science services ...

msn.com

$10
OFF

Why Thermo Fisher (TMO) Is Skyrocketing In 2025?

2 weeks from now

2 days ago · Thermo Fisher (NYSE:TMO)’s recent quarters have revealed steady (though not always spectacular) top-line results. In their third quarter of 2024, they reported around $10.6 …

investingchannel.com

FAQs about Why Thermo Fisher (TMO) is Skyrocketing in 2025? - MSN Coupon?

Is Thermo Fisher Scientific Inc (TMO) a safe dividend stock?

We recently published a list of 12 Best Safe Dividend Stocks for 2025. In this article, we are going to take a look at where Thermo Fisher Scientific Inc. (NYSE:TMO) stands against other best safe dividend stocks for 2025. The year 2024 was exceptional for US stocks, with the broader market climbing over 23% and the tech-focused NASDAQ gaining 29%. ...

Is Thermo Fisher a good stock to buy in 2025?

On the stock market side, Thermo Fisher (NYSE:TMO) had hovered in the low-to-mid-$500s in early January 2025. In my view, that reticence is pretty standard for a large-cap science services provider when overall biotech and pharmaceutical markets are a bit unpredictable. ...

Should you buy Thermo Fisher Scientific Inc (TMO)?

Thermo Fisher Scientific Inc (TMO) If you’ve ever benefited from a diagnostic test at a hospital, or taken medicine for a serious condition, there’s a good chance Thermo Fisher (NYSE:TMO) had a hand in making it possible. Thermo Fisher (NYSE:TMO)’s recent quarters have revealed steady (though not always spectacular) top-line results. ...

Is Thermo Fisher Scientific (TMO) a good CRISPR stock to buy?

Despite this, Thermo Fisher Scientific Inc. (NYSE:TMO) raised its full-year EPS guidance to a range of $21.35 to $22.07, up from the previous lower bound of $21.29. Revenue guidance remained steady, projected between $42.4 billion and $43.3 billion. Overall TMO ranks 1st on our list of the top CRISPR stocks to invest in. ...

Is TMO a good stock to buy in 2025?

Regardless, TMO makes the list due to a recent recovery from a selloff that started after its Q3 report. The stock has mostly traded sideways since 2021 and I see no reason to believe that it will deliver spectacular returns this year. Overall, TMO ranks 9th on our list of hottest mega-cap stocks so far in 2025. ...

Why did Thermo Fisher pull back in 2022?

It's been a fabulous performer over the last decade, but it’s struggled ever since the stock peaked at the end of 2021, pulled back hard in 2022... Now some of this was due to tougher comparisons as Thermo Fisher did great business in 2020 and 2021 as drug companies spent fortunes trying to figure out how to fight Covid. ...